According to Soligenix's latest financial reports and stock price the company's current number of shares outstanding is 10,379,854. At the end of 2023 the company had 10,379,854 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 10.37 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 23,091.08% | ๐บ๐ธ USA |
Pfizer PFE | 5,647,000,000 | 54,303.46% | ๐บ๐ธ USA |
Sanofi SNY | 2,507,200,000 | 24,054.48% | ๐ซ๐ท France |
Onconova Therapeutics ONTX | 21,002,937 | 102.34% | ๐บ๐ธ USA |
Athersys ATHX | 24,492,000 | 135.96% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | 1,121,000,000 | 10,699.77% | ๐ฎ๐ฑ Israel |
Cleveland BioLabs
CBLI | 12,919,100 | 24.46% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | 51,800,000 | 399.04% | ๐บ๐ธ USA |